A hidden strategy: How SARS-CoV-2 uses fibrinogen to evade the immune system
As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...
AI learns to 'speak' genetic 'dialect' for future SARS-CoV-2 mutation prediction
It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...
Binding to surface sugars enhances omicron variant's cell attachment, researchers discover
Researchers at Umeå University have discovered that the SARS-CoV-2 variant omicron has developed a stronger binding to human ...
Rheumatology Advisor4d
COVID-19 mRNA-1273 Vaccine Highly Protective in Pediatric Patients After 2 Doses
In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.
Scientific American4d
COVID Research Funding to Be Slashed, NIH Documents Show
Studies on COVID, climate change and South Africa are on the latest list of terminated grants by the U.S. National Institutes ...
Pulmonology Advisor6d
Ensitrelvir Effective for COVID-19 Prevention in Exposed Household Contacts
Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.
Scientists demonstrate pre-clinical proof of concept for next-gen DNA delivery technology
Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...
MyChesCo on MSN5d
Traws Pharma Announces Promising Data for Ratutrelvir as a COVID-19 Treatment
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has unveiled promising preclinical and Phase 1 data for ratutrelvir, its ...
Engadget5d
Nintendo Switch 2: Everything we know about specs, pricing, games and more
Partial solar eclipse: Where and when ...